標(biāo)題: Titlebook: Organmangel; Ist der Tod auf der Friedrich Breyer,Wolfgang Daele,Jochen Taupitz,Fri Book 2006 Springer-Verlag Berlin Heidelberg 2006 Finan [打印本頁] 作者: CILIA 時(shí)間: 2025-3-21 19:42
書目名稱Organmangel影響因子(影響力)
書目名稱Organmangel影響因子(影響力)學(xué)科排名
書目名稱Organmangel網(wǎng)絡(luò)公開度
書目名稱Organmangel網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Organmangel被引頻次
書目名稱Organmangel被引頻次學(xué)科排名
書目名稱Organmangel年度引用
書目名稱Organmangel年度引用學(xué)科排名
書目名稱Organmangel讀者反饋
書目名稱Organmangel讀者反饋學(xué)科排名
作者: modest 時(shí)間: 2025-3-21 22:25 作者: 易受騙 時(shí)間: 2025-3-22 02:15
Rahmenbedingungen und Einflussfaktoren auf die Verfügbarkeit von Organen作者: 東西 時(shí)間: 2025-3-22 05:19
V?lker-, europa- und verfassungsrechtliche Rahmenbedingungen作者: 協(xié)議 時(shí)間: 2025-3-22 10:47
Zusammenfassung, Handlungsoptionen und Empfehlungen作者: 憤慨點(diǎn)吧 時(shí)間: 2025-3-22 15:08
Krankenh?user an der Erkennung potentieller Organspender und die Erlaubnis einer Organentnahme durch Spender oder Angeh?rige. Es werden Strategien aufgezeigt, diese Faktoren positiv zu beeinflussen..978-3-540-33055-4作者: 清楚 時(shí)間: 2025-3-22 18:02 作者: LUMEN 時(shí)間: 2025-3-22 23:58 作者: 勤勉 時(shí)間: 2025-3-23 03:24 作者: 打折 時(shí)間: 2025-3-23 09:33 作者: 大量 時(shí)間: 2025-3-23 11:48 作者: Crater 時(shí)間: 2025-3-23 16:22
most aggressive malignant primary brain tumor in humans, glioblastoma multiforme. With comprehensive and cutting-edge information on therapeutic interventions and on the correct diagnosis of relevant neoplasms,978-94-024-0702-0978-94-007-5958-9作者: frozen-shoulder 時(shí)間: 2025-3-23 20:30
most aggressive malignant primary brain tumor in humans, glioblastoma multiforme. With comprehensive and cutting-edge information on therapeutic interventions and on the correct diagnosis of relevant neoplasms,978-94-024-0702-0978-94-007-5958-9作者: 艱苦地移動(dòng) 時(shí)間: 2025-3-23 22:37 作者: Muscularis 時(shí)間: 2025-3-24 03:01 作者: chronicle 時(shí)間: 2025-3-24 07:48
n provide an exquisitely sensitive sensor of disease. Because cancer cells shed DNA in the circu- tion, an event rarely seen in healthy individuals, tumor-specific genetic changes, such as promoter methylation or gene mutations, are detectable in DNA prepared from plasma or other body fluids. Cancer作者: 放肆的我 時(shí)間: 2025-3-24 11:07
. It also provides information on suppressing cellular senescence in the most common, and most aggressive malignant primary brain tumor in humans, glioblastoma multiforme. With comprehensive and cutting-edge information on therapeutic interventions and on the correct diagnosis of relevant neoplasms,作者: Entropion 時(shí)間: 2025-3-24 18:16 作者: 臭了生氣 時(shí)間: 2025-3-24 20:23
. It also provides information on suppressing cellular senescence in the most common, and most aggressive malignant primary brain tumor in humans, glioblastoma multiforme. With comprehensive and cutting-edge information on therapeutic interventions and on the correct diagnosis of relevant neoplasms,作者: 情節(jié)劇 時(shí)間: 2025-3-25 01:46 作者: 不再流行 時(shí)間: 2025-3-25 05:36
. It also provides information on suppressing cellular senescence in the most common, and most aggressive malignant primary brain tumor in humans, glioblastoma multiforme. With comprehensive and cutting-edge information on therapeutic interventions and on the correct diagnosis of relevant neoplasms,作者: Melanoma 時(shí)間: 2025-3-25 08:49
rs interested in new tumor biomarkers and physicians seekingBiomarkers are molecular indicators of a biological status and, as biochemical species, can be interrogated to evaluate disease status and therapeutic interventions. Biomarkers may be detectable in the blood, other body fluids, or tissues. 作者: infarct 時(shí)間: 2025-3-25 12:22 作者: SUGAR 時(shí)間: 2025-3-25 19:35
interventions. Biomarkers may be detectable in the blood, other body fluids, or tissues. The expectation is that the level of an informative biomarker is related to the specific type of disease present in the body. Hence, disease-relevant biomarkers can be used to measure the presence, progress, or作者: orthopedist 時(shí)間: 2025-3-25 21:34
rs interested in new tumor biomarkers and physicians seekingBiomarkers are molecular indicators of a biological status and, as biochemical species, can be interrogated to evaluate disease status and therapeutic interventions. Biomarkers may be detectable in the blood, other body fluids, or tissues. 作者: 法官 時(shí)間: 2025-3-26 01:17
r series focuses on the interrelationship between biological processes of aging and tumors—both dormant and quiescent. With detail supplied by numerous international researchers at the forefront of cancer research, the book examines a host of differing aspects of the topic. .Featured contributions a作者: 碳水化合物 時(shí)間: 2025-3-26 06:45 作者: interrogate 時(shí)間: 2025-3-26 10:14 作者: 多產(chǎn)魚 時(shí)間: 2025-3-26 14:17 作者: 哺乳動(dòng)物 時(shí)間: 2025-3-26 17:48
udes detailed information on therapies.Numerous color illust.With a particular emphasis on tumor dormancy in breast, lung, prostate, and liver cancers, as well as in melanoma, this first volume of a new Springer series focuses on the interrelationship between biological processes of aging and tumors作者: 失望未來 時(shí)間: 2025-3-27 01:01 作者: 蛙鳴聲 時(shí)間: 2025-3-27 04:05 作者: 投射 時(shí)間: 2025-3-27 09:21 作者: 不可比擬 時(shí)間: 2025-3-27 12:17
r series focuses on the interrelationship between biological processes of aging and tumors—both dormant and quiescent. With detail supplied by numerous international researchers at the forefront of cancer research, the book examines a host of differing aspects of the topic. .Featured contributions a作者: 連鎖,連串 時(shí)間: 2025-3-27 13:47
r series focuses on the interrelationship between biological processes of aging and tumors—both dormant and quiescent. With detail supplied by numerous international researchers at the forefront of cancer research, the book examines a host of differing aspects of the topic. .Featured contributions a作者: Permanent 時(shí)間: 2025-3-27 19:00
udes detailed information on therapies.Numerous color illust.With a particular emphasis on tumor dormancy in breast, lung, prostate, and liver cancers, as well as in melanoma, this first volume of a new Springer series focuses on the interrelationship between biological processes of aging and tumors
